AstraZeneca - July 2022 - case study 2

Start date:

Supporting and optimising treatment of Asthma patients in a Severe Asthma setting by objectively measuring adherence through the introduction of Turbu+, a digital intervention

Last modified: 29 May 2024

Last reviewed: 29 May 2024